Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

June 28, 2023

Study Completion Date

July 10, 2023

Conditions

Type II Diabetes

Interventions

DRUG

CKD-378 (low-dose)

Quaque day (QD), PO

Trial Locations (1)

Severance Hospital, Yonsei University College of Medicine, Seoul